eccogene glp-1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a receptor agonist for cardio-metabolic diseases AstraZeneca licenses Eccogene's oral GLP-1
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28





00188-2/asset/060af149-96d8-44a2-9e4d-318ecc8ae69e/main.assets/gr1_lrg.jpg)




















